Clinical trial
Pulse Sequence Development on 3T Magnetic Resonance Imaging/Spectroscopy
NCT00309504 · AHS Cancer Control Alberta, Other · Completed
Key facts
| NCT number | NCT00309504 |
|---|---|
| Title | Pulse Sequence Development on 3T Magnetic Resonance Imaging/Spectroscopy |
| Official title | Pulse Sequence Development on 3T Magnetic Resonance Imaging/Spectroscopy |
| Lead sponsor | AHS Cancer Control Alberta, Other |
| Collaborators | Cross Cancer Institute |
| Status | Completed |
| Study type | Observational |
| Conditions | Healthy |
| Enrollment | 40 |
| Start date | Mar 1, 2006 |
| Primary completion | Feb 1, 2012 |
| Completion | Feb 1, 2012 |
| First posted | Apr 3, 2006 |
| Last update posted | Feb 26, 2016 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: